An analytical comparison between point-of-care uric acid testing meters

被引:15
作者
Paraskos, Jonathan [1 ]
Berke, Zsofia [2 ]
Cook, Jason [2 ]
Miner, Jeffrey N. [3 ]
Braddock, Martin [1 ]
Platt, Adam [4 ]
Hughes, Glen [1 ]
机构
[1] AstraZeneca, Res & Dev, Macclesfield, Cheshire, England
[2] AstraZeneca, Res & Dev, Molndal, Sweden
[3] Ardea Biosci, Res & Dev, San Diego, CA USA
[4] AstraZeneca, Compan Diagnost, Cambridge, England
关键词
gout; diagnostic test; point-of-care systems; Uric acid; GOUT; HYPERURICEMIA; ALLOPURINOL; FEBUXOSTAT; MANAGEMENT; URATE; TRIAL;
D O I
10.1586/14737159.2016.1134326
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective: A key goal in gout treatment is achieving sustained serum uric acid (sUA) lowering. Point-of-care test (PoCT) meters provide convenient, rapid measures of sUA levels to monitor/adjust therapy. Four commercially available sUA PoCT meters were compared qualitatively (ease of use) and quantitatively (precision/accuracy). Methods: Liquid chromatography mass spectrometry (LC-MS) analysis was used as a laboratory reference method to compare precision of PoCT devices using blood samples from 20 healthy volunteers. Accuracy was compared against the LC-MS reference method and a laboratory clinical chemistry platform. Results: Qualitatively, EasyTouch((R)) GU and UASure were least user-friendly, requiring repeated attempts for accurate use. HumaSens and BeneCheck provided good usability and assay precision. Cross-validation of meter precision with laboratory-based uricase assay gave good correlations between both methods (R-2=0.8061 and 0.7605, respectively). Conclusion: UA PoCT meters can be important in managing gout, and the characteristics compared herein may enhance successful patient uptake.
引用
收藏
页码:373 / 382
页数:10
相关论文
共 25 条
[1]  
[Anonymous], 1997, HLTH TECHNOL ASSESS
[2]  
[Anonymous], 1992, FED REG
[3]   Febuxostat compared with allopurinol in patients with hyperuricemia and gout [J].
Becker, MA ;
Schumacher, HR ;
Wortmann, RL ;
MacDonald, PA ;
Eustace, D ;
Palo, WA ;
Streit, J ;
Joseph-Ridge, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (23) :2450-2461
[4]   An open-label, 6-month study of allopurinol safety in gout: The LASSO study [J].
Becker, Michael A. ;
Fitz-Patrick, David ;
Choi, Hyon K. ;
Dalbeth, Nicola ;
Storgard, Chris ;
Cravets, Matt ;
Baumgartner, Scott .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2015, 45 (02) :174-183
[5]   Immediate feedback of HbA1c levels improves glycemic control in type I and insulin-treated type 2 diabetic patients [J].
Cagliero, E ;
Levina, EV ;
Nathan, DM .
DIABETES CARE, 1999, 22 (11) :1785-1789
[6]   CME MULTIMEDIA ACTIVITY Managing Gout in the Primary Care Setting: What You and Your Patients Need to Know [J].
Doghramji, Paul P. ;
Edwards, N. Lawrence ;
McTigue, Joan .
AMERICAN JOURNAL OF MEDICINE, 2010, 123 (08) :S2-S2
[7]   Febuxostat: a new treatment for hyperuricaemia in gout [J].
Edwards, N. Lawrence .
RHEUMATOLOGY, 2009, 48 :15-19
[8]  
Hung YL, 2011, WEBMEDCENTRAL BIOMED, V2
[9]   2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia [J].
Khanna, Dinesh ;
Fitzgerald, John D. ;
Khanna, Puja P. ;
Bae, Sangmee ;
Singh, Manjit K. ;
Neogi, Tuhina ;
Pillinger, Michael H. ;
Merill, Joan ;
Lee, Susan ;
Prakash, Shraddha ;
Kaldas, Marian ;
Gogia, Maneesh ;
Perez-Ruiz, Fernando ;
Taylor, Will ;
Liote, Frederic ;
Choi, Hyon ;
Singh, Jasvinder A. ;
Dalbeth, Nicola ;
Kaplan, Sanford ;
Niyyar, Vandana ;
Jones, Danielle ;
Yarows, Steven A. ;
Roessler, Blake ;
Kerr, Gail ;
King, Charles ;
Levy, Gerald ;
Furst, Daniel E. ;
Edwards, N. Lawrence ;
Mandell, Brian ;
Schumacher, H. Ralph ;
Robbins, Mark ;
Wenger, Neil ;
Terkeltaub, Robert .
ARTHRITIS CARE & RESEARCH, 2012, 64 (10) :1431-1446
[10]   Portable electrochemical blood uric acid meter [J].
Kuo, CS ;
Hwu, CM ;
Lin, YH ;
Huang, YH ;
Kao, WY ;
Weih, MJ ;
Hsiao, LC ;
Kwok, CF ;
Ho, LT .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2002, 16 (02) :109-114